{"denomUnitsSelected":"Participants","description":"The observed rate of grade III-IV aGVHD among this subset will be calculated with 95% confidence intervals and compared descriptively to target rate.","reportingStatus":"NOT_POSTED","timeFrame":"Up to 10 years","title":"Feasibility of Rapid Taper of Immune Suppression for Subset of HSCT Patients With MRD >= 0.01% Pre- and/or Post-HSCT With no Acute Graft Versus Host Disease (aGVHD)","type":"OTHER_PRE_SPECIFIED"}